California Public Employees Retirement System Uro Gen Pharma Ltd. Transaction History

California Public Employees Retirement System

$135 Billion
Q2 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$15.2 - $20.94 $598,880 - $825,036	-39,400 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$17.54 - $25.43 $14,032 - $20,344	-800 Reduced 1.99%	39,400 $710,000
Q3 2020 Nov 05, 2020	BUY	$18.81 - $26.42 $18,810 - $26,420	1,000 Added 2.55%	40,200 $775,000
Q2 2020 Aug 12, 2020	SELL	$16.5 - $29.7 $44,517 - $80,130	-2,698 Reduced 6.44%	39,200 $1.02 Million
Q1 2020 May 12, 2020	BUY	$13.68 - $34.6 $82,052 - $207,530	5,998 Added 16.71%	41,898 $747,000
Q4 2019 Jan 27, 2020	BUY	$21.11 - $34.86 $348,315 - $575,190	16,500 Added 85.05%	35,900 $1.2 Million
Q3 2019 Oct 31, 2019	BUY	$23.83 - $36.44 $102,468 - $156,692	4,300 Added 28.48%	19,400 $462,000
Q2 2019 Aug 15, 2019	BUY	$32.75 - $40.35 $42,575 - $52,455	1,300 Added 9.42%	15,100 $543,000
Q4 2018 Feb 08, 2019	SELL	$38.35 - $50.39 $63,737 - $83,748	-1,662 Reduced 10.75%	13,800 $594,000
Q3 2018 Nov 13, 2018	SELL	$41.65 - $51.7 $59,267 - $73,569	-1,423 Reduced 8.43%	15,462 $730,000
Q2 2018 Aug 15, 2018	BUY	$48.35 - $65.33 $816,389 - $1.1 Million	16,885 New	16,885 $840,000

Others Institutions Holding URGN

# of Institutions

120

Shares Held

39.3M

Call Options Held

158K

Put Options Held

161K

Rtw Investments, LP New York, NY

3.56M
Shares

$44 Million
1.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3.3M
Shares

$40.9 Million
0.11% of portfolio
Ra Capital Management, L.P. Boston, MA

3.08M
Shares

$38.2 Million
0.78% of portfolio
Great Point Partners LLC Greenwich, CT

2.91M
Shares

$36 Million
12.93% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

2.45M
Shares

$30.3 Million
0.11% of portfolio

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account